SARS-COV-2: is it a risk for blood transfusion?

Langhi, Dante Mário; de Souza, Renato Cerqueira; Barros, Melca; De Santis, Gil Cunha; Kashima, Simone Haddad; Bordin, Jose Orlando

Langhi, Dante Mário; de Souza, Renato Cerqueira; Barros, Melca; De Santis, Gil Cunha; Kashima, Simone Haddad; Bordin, Jose Orlando.

Langhi DM; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. Electronic address: dlanghi@uol.com.br.
de Souza RC; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Barros M; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
De Santis GC; Fundacão Hemocentro de Ribeirão Preto, Ribeirão Preto, SP, Brazil.
Kashima SH; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.
Bordin JO; Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil; Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil.

Hematol Transfus Cell Ther ; 44(1): 100-103, 2022.

Article in English | MEDLINE | ID: covidwho-1377721

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Hematol Transfus Cell Ther Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google